– 2002: The Monsanto Company is spun off from Pharmacia as a separate company.
– 2003: Pfizer acquires Pharmacia.
– Pharmacia Corporation = Merger of Pharmacia & Upjohn Inc. and Monsanto in 2000. Monsanto, agricultural chemical division. Searle, pharmaceutical division.
– Pharmacia & Upjohn Inc. = Merger of Pharmacia AB and The Upjohn Company in 1995. Global headquarters relocated from the U.K. to the U.S. in 1998.
– Member of CropLife International.
– Member of The Corporate Council on Africa.
– Licensing agreement and R&D collaboration with Stokes Bio Limited to help accelerate the pace of new advancements in plant breeding.
– Facilities at North Carolina Research Campus become a part of one-of-a-kind facility under development in Kannapolis, North Carolina, and strategic alliance with the David H. Murdock Research Institute.
– Completion of Glyphosate Plant Expansion at Luling, Roundup agricultural herbicide production.
– New $2.4 million, 26,000-square-foot, corn breeding station in Flora, Mississippi.
– Acquisition, from Pfizer Inc., of the Chesterfield Village Research Center, 1.5 million-square-foot research center with 250 laboratories, 108 plant growth chambers and 2 acres of greenhouses.
– Haiti: $50,000 to the American Red Cross; 1st shipment of more than 60 tons of conventional hybrid corn and vegetable seeds through donated shipping, logistic and distribution services provided by Kuehne + Nagel and UPS; 2nd shipment of 70 tons of hybrid, conventional corn seed; Further donation and distribution of up to an additional 345 tons of conventional hybrid corn seed anticipated over the next 12 months.
– Expansion and increasing investments in collaboration with BASF to develop higher-yielding and stress-tolerant crops to include a fifth crop (corn, soy, cotton and canola). The original collaboration (2007) dedicated a joint budget of potentially $1.5 billion, the new agreement results in a potential additional investment of more than $1 billion by the companies over the life of the collaboration. Around 2012, the companies expect to introduce the world’s first genetically modified drought-tolerant corn, pending regulatory approvals.
– Wheat breeding technology collaboration agreement with InterGrain Pty Ltd.
– 3 year collaboration with AgraQuest Inc. to develope seed treatment products to control nematodes, disease and insects, and enhance plant growth and yield, using AgraQuest‘s collection of microbes.
– Agreement with South Dakota State University to create a new Ph.D. research fellowship program in plant breeding. Monsanto commits $1 million over 5 years for the program.
– $10 Million to rice and wheat research program administered by Texas AgriLife Research, an agency of the Texas A&M University System, for the next 5 years. Texas AgriLife Research also receives the largest private donation of cotton technology, including about 4,000 cotton molecular markers and associated information.
– The Water Utilization Learning Center, a $6 million facility designed for studying cropping systems comprised of world class genetics, agronomic practices and biotech traits including water-use efficiency technologies such as drought-tolerant cropping systems.
– Monsanto acquires the assets of WestBred LLC, a Montana-based company that specializes in wheat germplasm, the crop’s seed genetic material.
– Monsanto sells its global hybrid sunflower seed business to Syngenta for $160 million.
– The U.S. Bureau of Land Management begins distribution of a draft Environmental Impact Statement regarding a proposal by P4 Production LLC, a wholly owned subsidiary of Monsanto Company, to open one of North America’s most environmentally advanced phosphate mines.
– Monsanto among top rated businesses for lesbian, gay, bisexual and transgender workers according to a report by the Human Rights Campaign Foundation, the nation’s largest lesbian, gay, bisexual and transgender civil rights organization.
– Monsanto acquires Pfizer‘s Chesterfield Village Research Center located in Chesterfield for $435 million. Pfizer continues to have operations at Chesterfield Village through a lease agreement, primarily performing Biotherapeutic Pharmaceutical research. The site was originally built by the former Monsanto Company for approximately $150 million and opened in 1984.
– Monsanto opens first biotechnology research center in China. The Beijing research center participates in early-stage bioinformatics and genomics research, and serves as a base for collaborations with Chinese scientists. Monsanto also has research centers in the United States, Brazil and India.
– Monsanto acquires Marmot S.A., which operates Semillas Cristiani Burkard, a privately-held seed company headquartered in Guatemala City, Guatemala.
– Monsanto acquires Aly Participacoes Ltda., CanaVialis S.A. and Alellyx S.A., from Votorantim Novos Negocios Ltda. and its sister company, Votorantim Industrial S.A., both part of the Brazilian industrial conglomerate Votorantim Participacoes S.A.
– Monsanto acquires De Ruiter Seeds Company.
– Monsanto sales POSILAC bovine somatotropin brand and related business to Eli Lilly and Company.
– $2 Billion credit facility. The bank syndication was led by J.P.Morgan Securities Inc. and Citigroup Global Markets Inc., as co-lead arrangers and joint bookrunners.
– Share subscription agreement with Devgen.
– Monsanto increases investment in Mendel Biotechnology Inc.
– Newsham Genetics acquires Monsanto Choice Genetics.
– Monsanto acquires Agroeste Sementes S.A. (Brasil).
– Monsanto forms holding company, the International Seed Group Inc.
– Monsanto acquires Delta and Pine Land Company.
– Acquisitions of Seminis Inc. and Emergent Genetics Inc.
– American Seeds Inc. acquires NC+ Hybrids Inc., headquartered in Lincoln, Neb.
– Monsanto sales Monsanto Enviro-Chem Systems Inc. to MECS Inc., formed by the Enviro-Chem management team and an outside investor.
– American Seeds Inc. acquires 4 companies that are the shareowners of the CORE Group, including Fontanelle Hybrids, Stewart Seeds, Trelay Seeds and Stone Seeds. Also acquires Specialty Hybrids, a leader serving the Eastern Corn Belt.
– Monsanto forms American Seeds Inc., a holding company for mostly corn and soybeans.
– Monsanto’s American Seeds Inc. subsidiary acquires Channel Bio Corp. and its three seed brands: Crows Hybrid Corn, Midwest Seed Genetics and Wilson Seeds.
– NutraSweet Company is sold to J.W. Childs and Equal is sold to Merisant.
– Pharmacia acquires SUGEN.
– The original Monsanto purchases DeKalb Genetics Corp. and creates the porcine genetics subsidiary Monsanto Choice Genetics.
– The original Monsanto acquires Calgene, another biotech research company.
– Asgrow agronomics seed business is purchased by the original Monsanto.
– The original Monsanto purchases Holden’s Foundation Seeds L.L.C. and Corn States Hybrid Service L.L.C., a supplier of high quality foundation seed for the corn seed industry.
– The original Monsanto spins off its industrial chemical and fibers business as Solutia Inc.
– 1996: Monsanto acquires the plant biotechnology assets of Agracetus.
– 1985: Monsanto purchases G.D. Searle & Company and creates a subsidiary, the NutraSweet Company, which handled both NutraSweet and Equal.
– 1984: The Life Sciences Research Center opens in Chesterfield, MO., United States.
– 1982: Monsanto acquires the Jacob Hartz Seed Co., known for its soybean seed.
– 1981: A molecular biology group is set up and biotechnology is firmly established as Monsanto’s strategic research focus.
– 1975: A cell biology research program is established in the Agricultural Division.
– 1960: The Agricultural Division is established.
– European Union authorization for corn technology combinations Genuity VT Double PRO and YieldGard VT Triple.
– Full regulatory authorization in Mexico for importation of Genuity SmartStax, Genuity VT Triple PRO, and Genuity VT Double PRO.
– Full regulatory approval for Genuity VT Triple PRO corn in Argentina.
– Full regulatory approval for insect-protected and glyphosate-tolerant Bt Roundup Ready 2 Yield soybeans from the National Technical Biosafety Committee in Brazil.
– Completed regulatory submissions in the U.S., Canada, Japan, Mexico, and Korea for the world’s first biotech drought-tolerant corn product developed together with BASF.
– 80.000 hectáreas cultivadas con la variedad MON 810 representan más del 22% del cultivo de maíz en España y suponen una producción mayor que la del conjunto de los otros 6 países comunitarios que liberan semillas modificadas genéticamente para la producción de cereal.
– SmartStax, all-in-one corn trait platform, receives registration from the U.S. Environmental Protection Agency and regulatory authorization from the Canadian Food Inspection Agency.
– Monsanto Company and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, receive full Japanese regulatory approval for importation of grain produced from SmartStax.
– Approval from the Agriculture Ministry and Minister of Environment in Mexico to plant small-scale field trials of its corn traits in Sonora, Sinaloa and Tamaulipas. Monsanto corn technologies NK603 (Roundup Ready Corn 2), MON 89034 x NK603 (YieldGard VT PRO and Roundup Ready Corn 2) and MON 89034 x MON88017 (Genuity VT Triple PRO) conducted by local researchers.
– European Union authorization of YieldGard VT Pro (MON 89034) and YieldGard VT Rootworm/RR2 (MON 88017).
– The United States Department of Agriculture deregulates MON 89034, a new insect protection technology to be sold as YieldGard VT Triple PRO. Key international import approvals for MON 89034 have been achieved in Japan, Mexico, Canada and Colombia.
– Regulatory approvals for Roundup Ready 2 Yield soybeans in Mexico, Australia, New Zealand, China, Japan, the Philippines and Taiwan.
– La Unión Europea (UE) aprueba la importación, el procesamiento y el uso de YieldGard Taladradora de Maíz (MON810), apilado con el rasgo Roundup Ready Maíz 2 (NK603), para uso alimenticio y como pienso en la UE.
– El Comité Tecnológico Nacional de Bioseguridad de Brasil aprueba el producto contra insectos MON 810 de Monsanto, conocido YieldGard, para su uso comercial en Brasil.
– The Argentina Secretariat of Agriculture, Livestock, Fisheries and Food approves the stacked corn trait product containing the insect protection trait YieldGard Corn Borer with Roundup Ready Corn 2 technology.
– U.S. soybean exports: European Union, 10%; China, 38%.
– Record sales of $8.6 billion.
– La Comisión Europea autoriza el uso del maíz protegido contra plagas de taladro Yieldgard de Monsanto (MON 863) y productos procesados con él como comida e ingredientes de comida bajo la normativa Novel Foods Regulation.
– La Comisión Europea aprueba el uso del maíz Roundup Ready NK603 de Monsanto y sus derivados bajo el reglamento Nº 258/97 sobre nuevos alimentos y nuevos ingredientes alimentarios.
– Crecimiento del 293% en beneficios netos.
– El Ministerio de Agricultura Pesca y Alimentación da su autorización para incluir en el Registro de Variedades Comerciales el maíz Bt MON 810, resistente a insectos, aprobado por la UE en 1998. Desde 1969, Monsanto está presente en España.
– Doubling yields in core crops by 2030 compared to a base year of 2000, while reducing the amount of inputs required per unit produced by a third.
– Monsanto currently invests more than $2 million a day in research in order to meet this commitment to global agriculture.